Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet Douglas B. Brewer Summary Max Schultze published the first accurate and convincing...
Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet Douglas B. Brewer Summary Max Schultze published the first accurate and convincing...
BlankNew York Daily News - http://www.nydailynews.com Cell fones tied to tumors BY PAUL H.B. SHIN DAILY NEWS STAFF WRITER Saturday, April 1st, 2006 ...
BlankStudies showing health benefits of alcohol are flawed Thu Mar 30, 6:17 PM ET Most studies suggesting that moderate drinking staves off heart disease are...
BlankScientists warn parents on pesticides and plastics · Study suggests increased cancer risk in young · Families 'should consider switch to organic diets' ...
Dear Scott & all, Thanks for the additional and past information on Glossypol (aka AT-191). After all reading of the material, Glossypol sort of jumps out at...
Quest Diagnostics Launches the First Tests to Help Doctors Assess Status of Leukemia and Lymphoma in Patients Using Blood Plasma Instead of Bone Marrow Tuesday...
AT-101 is still in clinical trials. I believe that AT101 is a modified version of gossypol, so it is not available to anyone outside of a clinical trial. The...
Excerpted from: http://www.medscape.com/viewarticle/522652 Should New Results From ASH 2005 Alter Your Management of Non- Hodgkin's Lymphoma or Chronic...
Asian Pac J Allergy Immunol. 2005 Dec;23(4):197-203. Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: retrospective...
Leuk Res. 2006 Mar 30; [Epub ahead of print] Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia. Sellick GS, Catovsky D,...
[One researcher says those at risk for cancer shouldn't drink alcohol at all.] American Physiological Society Equivalent of 2-4 drinks daily fuels blood vessel...
[For our U.S. readers: Folks, it is time to pressure your House member to not go along with these cuts. Contrast these cuts with the amounts of money spent to...
[Sixth man making 'steady progress'. As would be expected, lawsuits are coming. I think it is likely that this is the end of this company.] Drugs trial...
Eur J Haematol. 2006 Mar 27; [Epub ahead of print] Response to splenectomy is durable after a certain point in time in adult patients with chronic immune...
Ann Hematol. 2006 Mar 21; [Epub ahead of print] Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic...
[This figure apparently just for the US. See: www.chicagogsb.edu/capideas/feb06/1.aspx ] Study: Cancer cure worth $50 trillion By UNITED PRESS INTERNATIONAL ...
Application of gold nanoparticles in the treatment of B-Chronic Lymphocytic Leukemia (CLL) Priyabrata Mukherjee, Ph.D. Mayo Clinic Abstract: Background and...
ZAP 70 methylation: a new prognostic marker in CLL David Oscier, M.D. Royal Bournemouth Hospital (United Kingdom) Abstract: Most patients with chronic...
CD38 and the fate of CLL cells: innocent bystander or culprit? Silvia Deaglio, M.D. University of Torino, Medical School Abstract: Several decades of...
"Development of Glycolycin as a novel therapeutic" Peng Huang, M.D., Ph.D. University of Texas M. D. Anderson Cancer Center Abstract: Significant progresses...
Targeting CLL antigens after stem cell transplantation John Gribben, M.D., DSc. Barts Cancer Center of Excellence/ The London School of Medicine (UK) Abstract:...
"Microenvironmental regulation of survival and growth of B lymphocytes from patients with Chronic Lymphocytic Leukemia (CLL)." Jan Burger, M.D., Ph.D. ...
A reminder that our meeting is coming up at the Belle Coolridge Library at 5600 South Land Park Drive in Sacramento, from 5 pm to 8 pm. I do have a list for...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
